| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10300041 | TCG FLUENT PHARMA | Liquid oral simvastatin compositions |
Apr, 2027
(2 years from now) | |
| US9597289 | TCG FLUENT PHARMA | Liquid oral simvastatin compositions |
Feb, 2030
(5 years from now) | |
Flolipid is owned by Tcg Fluent Pharma.
Flolipid contains Simvastatin.
Flolipid has a total of 2 drug patents out of which 0 drug patents have expired.
Flolipid was authorised for market use on 21 April, 2016.
Flolipid is available in suspension;oral dosage forms.
The generics of Flolipid are possible to be released after 23 February, 2030.
Drugs and Companies using SIMVASTATIN ingredient
Market Authorisation Date: 21 April, 2016
Treatment: NA
Dosage: SUSPENSION;ORAL
More Information on Dosage
FLOLIPID family patents
